Newbridge Financial Services Group’s Lixte Biotechnology Warrants LIXTW Stock Holding History

Newbridge Financial Services Group’s Portfolio LIXTW Stock Details LIXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,500	Closed	-$361	–	1334
2025 Q3	$361	Hold	2,500	–	–	﹤0.01%	1229
2025 Q2	$72	Buy	+2,500	New	+$82	﹤0.01%	1290

Newbridge Financial Services Group's LIXTW Position: Q4 2025 in Review

Newbridge Financial Services Group sold out of Lixte Biotechnology Warrants (LIXTW) in Q4 2025, closing a stake of 2,500 shares — an estimated $361 sold.

Newbridge Financial Services Group first reported a position in LIXTW in Q2 2025 and held it in 2 quarters. The position peaked at $361 in Q3 2025. 0 funds tracked by Wall St. Rank hold LIXTW as of Q4 2025.

Newbridge Financial Services Group reported no remaining Lixte Biotechnology Warrants position as of Q4 2025 after selling out during the quarter.
Newbridge Financial Services Group sold 2,500 Lixte Biotechnology Warrants shares in Q4 2025, an estimated $361.
Newbridge Financial Services Group first reported a position in Lixte Biotechnology Warrants in Q2 2025 and held it in 2 quarters.
Newbridge Financial Services Group's Lixte Biotechnology Warrants position peaked at $361 in Q3 2025.
0 funds tracked by Wall St. Rank held Lixte Biotechnology Warrants as of Q4 2025.

Based on Newbridge Financial Services Group's 13F filing for Q4 2025, filed 21 Jan 2026.